HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,584,504 | -28.8% | 78,868 | -23.5% | 0.00% | – |
| Q2 2023 | $3,628,370 | +105.0% | 103,108 | +90.3% | 0.00% | – |
| Q1 2023 | $1,770,000 | +34517.6% | 54,194 | -41.6% | 0.00% | -100.0% |
| Q4 2022 | $5,113 | -99.9% | 92,805 | -20.2% | 0.00% | 0.0% |
| Q3 2022 | $5,150,000 | +8.9% | 116,285 | +19.9% | 0.00% | 0.0% |
| Q2 2022 | $4,729,000 | +283.2% | 96,963 | +282.6% | 0.00% | – |
| Q1 2022 | $1,234,000 | +29.5% | 25,343 | +13.5% | 0.00% | – |
| Q4 2021 | $953,000 | +161.1% | 22,326 | +134.5% | 0.00% | – |
| Q3 2021 | $365,000 | +28.1% | 9,520 | -6.1% | 0.00% | – |
| Q2 2021 | $285,000 | -49.6% | 10,137 | -40.8% | 0.00% | – |
| Q1 2021 | $565,000 | -19.7% | 17,122 | -12.1% | 0.00% | – |
| Q4 2020 | $704,000 | +5766.7% | 19,488 | +4948.7% | 0.00% | – |
| Q3 2020 | $12,000 | – | 386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |